Organic Lifestyle Magazine

U.S. is Nowhere Coronavirus Herd Immunity, Says New Study

by
Last updated on: October 5, 2020

image_pdfimage_print

The United States is nowhere near herd immunity from COVID-19, according to a new study that analyzed antibody data from more than 28,000 dialysis patients across the United States.

During the first wave of the COVID-19 pandemic, fewer than 10% of the US adult population formed antibodies against SARS-CoV-2, and fewer than 10% of those with antibodies were diagnosed. Public health efforts to limit SARS-CoV-2 spread need to especially target racial and ethnic minority and densely populated communities.”

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA
Related: COVID Second Wave Is Happening All Over Europe, Except in Sweden

Herd immunity has been put forth as a potential coronavirus management option for the U.S. If that strategy worked, it would be a boon for business, but this study indicates that that level of exposure isn’t happening. Even if it was, scientists are still not sure long antibodies last.




[ubermenu config_id="main" menu="205"]
Kristina Martin

Kristina Martin

Kristina works at Green Lifestyle Market. A few years ago Kristina was no stranger to illness, but she decided to pursue health and vitality through natural means when she became pregnant. She quickly learned that she could prevent morning sickness and other common ailments other pregnant woman experienced with the right diet. After a healthy home birth, and a beautiful child, she never looked back. Kristina has not had so much as a cold since, and at two years old and unvaccinated, neither has her child. She's passionate about natural health, environmental conservation, and raising her healthy baby without pharmaceuticals.

Bio Page  -  Author's Website